Novel radiopharmaceutical tracks ‘master switch’ protein responsible for cancer growth
Study finds association between head impacts and imaging changes in youth football players
15 June 2021Young adults’ alcohol use increases when casually dating
15 June 2021Novel radiopharmaceutical tracks ‘master switch’ protein responsible for cancer growth
A protein that is critical in cancer cell metabolism has been imaged for the first time with a newly developed radiopharmaceutical, 18F-DASA-23. Imaging with this novel agent has the potential to improve the assessment of treatment response for patients, specifically those with brain tumors. This study was presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.
